<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.psychiatrienet.nl/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Roland</id>
	<title>Psychiatrienet - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.psychiatrienet.nl/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Roland"/>
	<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/wiki/Special:Contributions/Roland"/>
	<updated>2026-05-15T19:25:52Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.31.6</generator>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Clozapine-Lurasidone&amp;diff=6913</id>
		<title>Clozapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Clozapine-Lurasidone&amp;diff=6913"/>
		<updated>2015-03-05T12:57:46Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Clozapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1:''' gradually reduce the dose of haloperidol with 12,5-25 mg a week &amp;lt;ref&amp;gt;[http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1415944617205.pdf MHRA. SmPC Clozaril 100 mg tablets.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
| start = &lt;br /&gt;
* '''Week 1:''' approx. 25% of target dose &lt;br /&gt;
* '''Week 2:''' approx. 50% of target dose &lt;br /&gt;
* '''Week 3:''' approx. 75% of target dose&lt;br /&gt;
* '''Week 4:''' target dose  &lt;br /&gt;
| info = {{ClozEffect}} {{caveQT}} &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Clozapine-Lurasidone&amp;diff=6912</id>
		<title>Clozapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Clozapine-Lurasidone&amp;diff=6912"/>
		<updated>2015-03-05T12:46:28Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Clozapine | to = Lurasidon | stop =  * '''Day 1:''' gradually reduce the dose of haloperidol with 12,5 mg a week  | start =  * '''Week 1:''' approx. 25% of...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Clozapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1:''' gradually reduce the dose of haloperidol with 12,5 mg a week &lt;br /&gt;
| start = &lt;br /&gt;
* '''Week 1:''' approx. 25% of target dose &lt;br /&gt;
* '''Week 2:''' approx. 50% of target dose &lt;br /&gt;
* '''Week 3:''' approx. 75% of target dose&lt;br /&gt;
* '''Week 4:''' target dose  &lt;br /&gt;
| info = {{ClozEffect}} {{caveQT}} &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Sertindole-Lurasidone&amp;diff=6911</id>
		<title>Sertindole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Sertindole-Lurasidone&amp;diff=6911"/>
		<updated>2015-03-05T12:37:53Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Sertindole | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of sertindole to 50% of the dose. * '''Day 8-14:''' gradually reduce the d...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Sertindole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of sertindole to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of sertindole to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of sertindole.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt;   &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Amisulpride-Lurasidone&amp;diff=6910</id>
		<title>Amisulpride-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Amisulpride-Lurasidone&amp;diff=6910"/>
		<updated>2015-03-05T12:37:00Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Amisulpride&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of amisulpride to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of amisulpride to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of amisulpride.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt;   &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Amisulpride-Lurasidone&amp;diff=6909</id>
		<title>Amisulpride-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Amisulpride-Lurasidone&amp;diff=6909"/>
		<updated>2015-03-05T12:36:37Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Amisulpride | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of pimozide to 50% of the dose. * '''Day 8-14:''' gradually reduce the do...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Amisulpride&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of pimozide to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of pimozide to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of pimozide.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt;   &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Sulpiride-Lurasidone&amp;diff=6908</id>
		<title>Sulpiride-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Sulpiride-Lurasidone&amp;diff=6908"/>
		<updated>2015-03-05T12:28:58Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Sulpiride | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of sulpiride to 50% of the dose. * '''Day 8-14:''' gradually reduce the dos...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Sulpiride&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of sulpiride to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of sulpiride to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of sulpiride.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt;   &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Pimozide-Lurasidone&amp;diff=6907</id>
		<title>Pimozide-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Pimozide-Lurasidone&amp;diff=6907"/>
		<updated>2015-03-05T12:27:51Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Pimozide | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of pimozide to 50% of the dose. * '''Day 8-14:''' gradually reduce the dose ...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Pimozide&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of pimozide to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of pimozide to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of pimozide.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt;   &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Chlorpromazine-Lurasidone&amp;diff=6906</id>
		<title>Chlorpromazine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Chlorpromazine-Lurasidone&amp;diff=6906"/>
		<updated>2015-03-05T12:20:50Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Chlorpromazine | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of chlorpromazine to 50% of the dose. * '''Day 8-14:''' gradually redu...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Chlorpromazine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of chlorpromazine to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of chlorpromazine to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of chlorpromazine.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Haloperidol-Lurasidone&amp;diff=6905</id>
		<title>Haloperidol-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Haloperidol-Lurasidone&amp;diff=6905"/>
		<updated>2015-03-05T12:19:37Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Haloperidol | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of haloperidol to 50% of the dose. * '''Day 8-14:''' gradually reduce the...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Haloperidol&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of haloperidol to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of haloperidol to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of haloperidol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Ziprasidone-Lurasidone&amp;diff=6904</id>
		<title>Ziprasidone-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Ziprasidone-Lurasidone&amp;diff=6904"/>
		<updated>2015-03-05T12:18:03Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Ziprasidone | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of aiprasidone to 50% of the dose. * '''Day 8-14:''' gradually reduce the...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Ziprasidone&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of aiprasidone to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of ziprasidone to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of ziprasidone.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Risperidone-Lurasidone&amp;diff=6903</id>
		<title>Risperidone-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Risperidone-Lurasidone&amp;diff=6903"/>
		<updated>2015-03-05T12:16:59Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Risperidone | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of risperidone to 50% of the dose. * '''Day 8-14:''' gradually reduce the...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Risperidone&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of risperidone to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of risperidone to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of risperidone.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6902</id>
		<title>Aripiprazole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6902"/>
		<updated>2015-03-05T12:16:00Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Aripiprazole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of aripiprazole to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of aripiprazole to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of aripiprazol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Quetiapine-Lurasidone&amp;diff=6901</id>
		<title>Quetiapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Quetiapine-Lurasidone&amp;diff=6901"/>
		<updated>2015-03-05T12:15:17Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Quetiapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of quetiapine to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of queatipne to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of quetiapine.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Olanzapine-Lurasidone&amp;diff=6900</id>
		<title>Olanzapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Olanzapine-Lurasidone&amp;diff=6900"/>
		<updated>2015-03-05T12:14:45Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Olanzapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of olanzapine to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of olanzapine to 0% of the dose&lt;br /&gt;
* '''Day 14:''' stop administration of olanzapine.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Quetiapine-Lurasidone&amp;diff=6899</id>
		<title>Quetiapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Quetiapine-Lurasidone&amp;diff=6899"/>
		<updated>2015-03-05T12:12:54Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Quetiapine | to = Lurasidon | stop =  * '''Day 1-7:''' gradually reduce the dose of quetiapine to 50% of the dose. * '''Day 8-14:''' gradually reduce the d...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Quetiapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' gradually reduce the dose of quetiapine to 50% of the dose.&lt;br /&gt;
* '''Day 8-14:''' gradually reduce the dose of queatipne to 25% of the dose&lt;br /&gt;
* '''Day 15:''' stop administration of quetiapine.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Olanzapine-Lurasidone&amp;diff=6898</id>
		<title>Olanzapine-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Olanzapine-Lurasidone&amp;diff=6898"/>
		<updated>2015-03-05T11:35:27Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Olanzapine | to = Lurasidon | stop =  * '''Day 1-7:''' reduce the dose of olanzapine to 50% of the dose. * '''Day 14:''' stop administration of olanzapine....'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Olanzapine&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' reduce the dose of olanzapine to 50% of the dose.&lt;br /&gt;
* '''Day 14:''' stop administration of olanzapine.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6897</id>
		<title>Aripiprazole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6897"/>
		<updated>2015-03-05T11:34:32Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Aripiprazole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' reduce the dose of aripiprazol to 50% of the dose.&lt;br /&gt;
* '''Day 14:''' stop administration of aripiprazol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon on day 1 in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6896</id>
		<title>Aripiprazole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6896"/>
		<updated>2015-03-05T11:33:42Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Aripiprazole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' reduce the dose of aripiprazol to 50% of the dose.&lt;br /&gt;
* '''Day 14:''' stop administration of aripiprazol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dose of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
* It is also possible to start administration of lurasidon in a dose of 80 mg/day. &amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/23473350 McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6895</id>
		<title>Aripiprazole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6895"/>
		<updated>2015-03-05T11:28:57Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Aripiprazole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' reduce the dose of aripiprazol to 50% of the dose.&lt;br /&gt;
* '''Day 14:''' stop administration of aripiprazol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dosage of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6894</id>
		<title>Aripiprazole-Lurasidone</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Aripiprazole-Lurasidone&amp;diff=6894"/>
		<updated>2015-03-05T11:28:29Z</updated>

		<summary type="html">&lt;p&gt;Roland: Created page with '{{Drugswitch  | from = Aripiprazole | to = Lurasidon | stop =  * '''Day 1-7:''' reduce the dose of aripiprazol to 50% of the dose. * '''Day 14:''' stop administration of aripipra...'&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = Aripiprazole&lt;br /&gt;
| to = Lurasidon&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1-7:''' reduce the dose of aripiprazol to 50% of the dose.&lt;br /&gt;
* '''Day 14:''' stop administration of aripiprazol.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-7:''' start administration of lurasidon in a dosage of 40 mg/day.&lt;br /&gt;
* '''Day 8-14:''' increase the dose of lurasidon to 80 mg/day if necessary. Note: Continue the dose of lurasidone 40 mg/day if the patiënt is stable.  &lt;br /&gt;
| view = StopAbruptly21StartGradually2.jpg&lt;br /&gt;
| info = {{caveQT}}&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Vortioxetine-citalopram&amp;diff=6893</id>
		<title>Vortioxetine-citalopram</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Vortioxetine-citalopram&amp;diff=6893"/>
		<updated>2015-03-04T15:53:01Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = vortioxetine &lt;br /&gt;
| to = citalopram&lt;br /&gt;
| stop = &lt;br /&gt;
* '''Day 1:''' reduce dosage of vortioxetine to 5 mg/day.&lt;br /&gt;
* '''Day 7:''' stop administration of vortioxetine.&lt;br /&gt;
| start = &lt;br /&gt;
* No wash-out period is needed. &lt;br /&gt;
* Start citalopram the next day in normal dosage of 20 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* {{theorSS}}&amp;lt;ref&amp;gt;[http://www.ema.europa.eu/docs/nl_NL/document_library/EPAR_-_Product_Information/human/002717/WC500159449.pdf European Medicines Agency. SmPC Brintellix 5 mg.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Trazodone-vortioxetine&amp;diff=6892</id>
		<title>Trazodone-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Trazodone-vortioxetine&amp;diff=6892"/>
		<updated>2015-03-04T15:50:03Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = trazodone&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of trazodone to a maximum of 150 mg/day, when this dosage is  &amp;gt; 150 mg/day. &lt;br /&gt;
* '''Day 1:''' reduce the dosage of trazodone to 75-100 mg/day.&lt;br /&gt;
* '''Day 8:''' when a dosage of 75 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 8:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* The content of trazodone in the tablet, for example 100 mg or 150 mg, determines which exact doses are given. &lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Duloxetine-vortioxetine&amp;diff=6891</id>
		<title>Duloxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Duloxetine-vortioxetine&amp;diff=6891"/>
		<updated>2015-03-04T15:49:36Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = duloxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of duloxetine to a maximum of 60 mg/day, when this dosage is &amp;gt; 60 mg/day. &lt;br /&gt;
* '''Day 1-7:''' reduce dosage of duloxetine from 60 mg/day to 30 mg/day&lt;br /&gt;
* '''Day 8-14:''' reduce dosage of duloxetine to 30 mg/day to 0 mg/day&lt;br /&gt;
* '''Day 15:''' stop administration of duloxetine. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 15:''' Start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Duloxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6890</id>
		<title>Venlafaxine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6890"/>
		<updated>2015-03-04T15:48:42Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downVenla}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6889</id>
		<title>Venlafaxine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6889"/>
		<updated>2015-03-04T15:48:33Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downVenla}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6888</id>
		<title>Venlafaxine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6888"/>
		<updated>2015-03-04T15:47:51Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downVenla}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info:&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Sertraline-vortioxetine&amp;diff=6887</id>
		<title>Sertraline-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Sertraline-vortioxetine&amp;diff=6887"/>
		<updated>2015-03-04T15:47:30Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = sertraline&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of sertraline to a maximum of 15 mg/day, when this dosage is  &amp;gt; 50 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 50 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6886</id>
		<title>Paroxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6886"/>
		<updated>2015-03-04T15:47:02Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downparox}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Paroxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Fluvoxamine-vortioxetine&amp;diff=6885</id>
		<title>Fluvoxamine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Fluvoxamine-vortioxetine&amp;diff=6885"/>
		<updated>2015-03-04T15:46:37Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluvoxamine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of fluvoxamine to a maximum of 50 mg/day, when this dosage is  &amp;gt; 50 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 50 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Fluvoxamine is a strong inhibitor of CYP2C9, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Fluoxetine-vortioxetine&amp;diff=6884</id>
		<title>Fluoxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Fluoxetine-vortioxetine&amp;diff=6884"/>
		<updated>2015-03-04T15:46:08Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is  &amp;gt; 10 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Fluoxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6883</id>
		<title>Escitalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6883"/>
		<updated>2015-03-04T15:45:50Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = escitalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is  &amp;gt; 10 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, , but care is needed. &lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Escitalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6882</id>
		<title>Citalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6882"/>
		<updated>2015-03-04T15:45:30Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = citalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' Gradually reduce dosage of citalopram to a maximum of 20 mg/day, when this dosage is &amp;gt; 20 mg/day. &lt;br /&gt;
* '''Day 1:''' When a dosage of 20 mg/day is reached, stop administration. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' Start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Fluoxetine-vortioxetine&amp;diff=6881</id>
		<title>Fluoxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Fluoxetine-vortioxetine&amp;diff=6881"/>
		<updated>2015-03-04T15:44:00Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = fluoxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is  &amp;gt; 10 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Fluoxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after intiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6879</id>
		<title>Escitalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6879"/>
		<updated>2015-03-04T15:43:03Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = escitalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is  &amp;gt; 10 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, , but care is needed. &lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Escitalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after intiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6877</id>
		<title>Citalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6877"/>
		<updated>2015-03-04T15:41:17Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = citalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' Gradually reduce dosage of citalopram to a maximum of 20 mg/day, when this dosage is &amp;gt; 20 mg/day. &lt;br /&gt;
* '''Day 1:''' When a dosage of 20 mg/day is reached, stop administration. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' Start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after intiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.&amp;lt;ref&amp;gt;[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]&amp;lt;/ref&amp;gt; &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6876</id>
		<title>Venlafaxine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Venlafaxine-vortioxetine&amp;diff=6876"/>
		<updated>2015-03-04T15:24:48Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = venlafaxine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downVenla}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Trazodone-vortioxetine&amp;diff=6875</id>
		<title>Trazodone-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Trazodone-vortioxetine&amp;diff=6875"/>
		<updated>2015-03-04T15:21:59Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = trazodone&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of trazodone to a maximum of 150 mg/day, when this dosage is  &amp;gt; 150 mg/day. &lt;br /&gt;
* '''Day 1:''' reduce the dosage of trazodone to 75-100 mg/day.&lt;br /&gt;
* '''Day 8:''' when a dosage of 75 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 8:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* The content of trazodone in the tablet, for example 100 mg or 150 mg, determines which exact doses are given. &lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Tranylcypromine-vortioxetine&amp;diff=6874</id>
		<title>Tranylcypromine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Tranylcypromine-vortioxetine&amp;diff=6874"/>
		<updated>2015-03-04T15:17:10Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = tranylcypromine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of tranylcypromine with 10-20 mg/week. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 1-14:''' a wash-out period of two weeks is necessary. &lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
* The wash-out period is necessary for the MAO enzymes to restore their function.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6873</id>
		<title>Paroxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6873"/>
		<updated>2015-03-04T15:14:31Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downparox}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Paroxetine is a strong inhibitor of CYP2D6, which metabolizes vortioxetine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Sertraline-vortioxetine&amp;diff=6872</id>
		<title>Sertraline-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Sertraline-vortioxetine&amp;diff=6872"/>
		<updated>2015-03-04T15:13:46Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = sertraline&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of sertraline to a maximum of 15 mg/day, when this dosage is  &amp;gt; 50 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 50 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6871</id>
		<title>Paroxetine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Paroxetine-vortioxetine&amp;diff=6871"/>
		<updated>2015-03-04T15:11:52Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = paroxetine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
{{downparox}}&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Nortriptyline-vortioxetine&amp;diff=6870</id>
		<title>Nortriptyline-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Nortriptyline-vortioxetine&amp;diff=6870"/>
		<updated>2015-03-04T15:09:24Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = nortriptyline&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of nortriptyline to a maximum of 100 mg/day.&lt;br /&gt;
* '''Day 1:''' reduce dosage of nortriptyline to 50 mg/day.&lt;br /&gt;
* '''Day 3:''' reduce dosage of nortriptyline to 25 mg/day.&lt;br /&gt;
* '''Day 8:''' stop administration of nortriptyline.&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a normal dosage of 10 mg/day.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6869</id>
		<title>Citalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6869"/>
		<updated>2015-03-04T15:05:05Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = citalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' Gradually reduce dosage of citalopram to a maximum of 20 mg/day, when this dosage is &amp;gt; 20 mg/day. &lt;br /&gt;
* '''Day 1:''' When a dosage of 20 mg/day is reached, stop administration. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, but care is needed.&lt;br /&gt;
* '''Day 1:''' Start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* {{theorSS}}&amp;lt;ref&amp;gt;[[European Medicines Agency]] | SmPC Brintellix 5 mg. &amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6868</id>
		<title>Escitalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Escitalopram-vortioxetine&amp;diff=6868"/>
		<updated>2015-03-04T15:04:49Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = escitalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of escitalopram to a maximum of 10 mg/day, when this dosage is  &amp;gt; 10 mg/day. &lt;br /&gt;
* '''Day 1:''' when a dosage of 10 mg/day is reached, stop administration&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary, , but care is needed. &lt;br /&gt;
* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Escitalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6867</id>
		<title>Citalopram-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Citalopram-vortioxetine&amp;diff=6867"/>
		<updated>2015-03-04T15:01:22Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = citalopram&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' Gradually reduce dosage of citalopram to a maximum of 20 mg/day, when this dosage is &amp;gt; 20 mg/day. &lt;br /&gt;
* '''Day 1:''' When a dosage of 20 mg/day is reached, stop administration. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 1:''' Start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info =&lt;br /&gt;
* Citalopram is a weak inhibitor of CYP2D6, which metabolizes vortioxeine. &lt;br /&gt;
* {{theorSS}}&amp;lt;ref&amp;gt;[[European Medicines Agency]] | SmPC Brintellix 5 mg. &amp;lt;/ref&amp;gt;&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Moclobemide-vortioxetine&amp;diff=6866</id>
		<title>Moclobemide-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Moclobemide-vortioxetine&amp;diff=6866"/>
		<updated>2015-03-04T14:58:38Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = moclobemide&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of moclobemide to a maximum of 300 mg/day. &lt;br /&gt;
* '''Day 1:''' reduce the dosage of moclobemide to 150 mg/day.&lt;br /&gt;
* '''Day 8:''' stop administration of moclobemide.&lt;br /&gt;
| start = &lt;br /&gt;
* '''Day 8-9:''' a wash-out period of two days is necessary. &lt;br /&gt;
* '''Day 10:''' start administration of vortioxetine in a normale dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Moclobemide-vortioxetine&amp;diff=6865</id>
		<title>Moclobemide-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Moclobemide-vortioxetine&amp;diff=6865"/>
		<updated>2015-03-04T14:58:27Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = moclobemide&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of moclobemide to a maximum of 300 mg/day. &lt;br /&gt;
* '''Day 1:''' reduce the dosage of moclobemide to 150 mg/day.&lt;br /&gt;
* '''Day 8:''' stop administration of moclobemide.&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 8-9:''' a wash-out period of two days is necessary. &lt;br /&gt;
* '''Day 10:''' start administration of vortioxetine in a normale dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Mirtazapine-vortioxetine&amp;diff=6864</id>
		<title>Mirtazapine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Mirtazapine-vortioxetine&amp;diff=6864"/>
		<updated>2015-03-04T14:54:00Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = mirtazapine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of mirtazapine to a maximum of 30 mg/day, when this dosage is  &amp;gt; 30 mg/day. &lt;br /&gt;
* '''Day 1:''' reduce the dosage of 30 mg/day to 15 mg/day.&lt;br /&gt;
* '''Day 8:''' stop administration of mirtazapine. &lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 8:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Maprotiline-vortioxetine&amp;diff=6863</id>
		<title>Maprotiline-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Maprotiline-vortioxetine&amp;diff=6863"/>
		<updated>2015-03-04T14:41:49Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = maprotiline&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of maprotiline to a maximum of 75 mg/day.&lt;br /&gt;
* '''Day 1:''' reduce dosage of maprotiline to 50 mg/day.&lt;br /&gt;
* '''Day 8:''' reduce dosage of maprotiline to 25 mg/day.&lt;br /&gt;
* '''Day 14:''' stop dosage of maprotiline.&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 15:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
	<entry>
		<id>https://wiki.psychiatrienet.nl/w/index.php?title=Imipramine-vortioxetine&amp;diff=6862</id>
		<title>Imipramine-vortioxetine</title>
		<link rel="alternate" type="text/html" href="https://wiki.psychiatrienet.nl/w/index.php?title=Imipramine-vortioxetine&amp;diff=6862"/>
		<updated>2015-03-04T14:34:10Z</updated>

		<summary type="html">&lt;p&gt;Roland: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Drugswitch &lt;br /&gt;
| from = imipramine&lt;br /&gt;
| to = vortioxetine &lt;br /&gt;
| stop = &lt;br /&gt;
* '''Before day 1:''' gradually reduce dosage of imipramine to a maximum of 75 mg/day.&lt;br /&gt;
* '''Day 1:''' reduce dosage of imipramine to 50 mg/day.&lt;br /&gt;
* '''Day 3:''' reduce dosage of imipramine to 25 mg/day.&lt;br /&gt;
* '''Day 8:''' stop administration of imipramine.&lt;br /&gt;
| start = &lt;br /&gt;
* A wash-out period is not necessary.&lt;br /&gt;
* '''Day 8:''' start administration of vortioxetine in a dosage of 10 mg/day.&lt;br /&gt;
| info = &lt;br /&gt;
* Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>Roland</name></author>
		
	</entry>
</feed>